AxoGen (NASDAQ:AXGN) Rating Lowered to Hold at StockNews.com

StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday. A number of other research analysts have also weighed in on AXGN. Cantor Fitzgerald reissued an overweight rating and set a $12.00 price target on shares of AxoGen in […]

Related Keywords

Switzerland , Swiss , Peterj Mariani , , Cantor Fitzgerald , Raymond James Financial Services Advisors Inc , Metlife Investment Management , Axogen Company Profile , Jpmorgan Chase Co , Vanguard Group Inc , Axogen Inc , Canaccord Genuity Group , Swiss National Bank , Free Report , Genuity Group , Moderate Buy , National Bank , James Financial Services Advisors , Life Investment Management , Vanguard Group , Get Free Report , Avance Nerve Graft , Axoguard Nerve Connector , Axoguard Nerve Protector , Axogen Daily , Axogen , Nasdaq Axgn , Axgn , Medical , Downgrade , Stocknews Com ,